Since DCs are a rapid-onset and frequent complication of diabetes mellitus, the authors attempted to define whether β-CM-7 could exert antioxidant protection through the modulation of transcription factors such as FoxO1 and Sp1, known regulators of oxidative stress responses. This evidence concerns the gene FOXO1 and diabetes mellitus.